These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15816204)

  • 21. Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus.
    Nagi DK; Ali VM; Yudkin JS
    Diabet Med; 1996 Aug; 13(8):753-7. PubMed ID: 8862952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes.
    Hanefeld M; Haffner SM; Menschikowski M; Koehler C; Temelkova-Kurktschiev T; Wildbrett J; Fischer S
    Diabetes Res Clin Pract; 2002 Mar; 55(3):221-7. PubMed ID: 11850098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics and pharmacokinetics of intravenous glibenclamide in Caucasian and Chinese patients with type-2 diabetes.
    Jönsson A; Chan JC; Rydberg T; Vaaler S; Hallengren B; Cockram CS; Critchley JA; Melander A
    Eur J Clin Pharmacol; 2000 Jan; 55(10):721-7. PubMed ID: 10663449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of total and intact proinsulins to hyperinsulinism in subjects with obesity, impaired glucose tolerance or type 2 diabetes.
    Blicklé JF; Sapin R; Andrès E
    Diabetes Metab; 2000 Sep; 26(4):274-80. PubMed ID: 11011219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetes.
    Panahloo A; Mohamed-Ali V; Andrés C; Denver AE; Yudkin JS
    Metabolism; 1998 Jun; 47(6):637-43. PubMed ID: 9627359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.
    Prigeon RL; Jacobson RK; Porte D; Kahn SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
    MacNamara CM; Barrow BA; Manley SE; Levy JC; Clark A; Turner RC
    Diabetes Res Clin Pract; 2000 Oct; 50(2):117-26. PubMed ID: 10960722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes.
    Jönsson A; Hallengren B; Rydberg T; Melander A
    Diabetes Obes Metab; 2001 Dec; 3(6):403-9. PubMed ID: 11903411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial.
    Rissanen A; Howard CP; Botha J; Thuren T;
    Diabetes Obes Metab; 2012 Dec; 14(12):1088-96. PubMed ID: 22726220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related changes of proinsulin processing in diabetic and non-diabetic Japanese individuals.
    Yoshino H; Kawakami K; Yoshino G; Hirose T
    Geriatr Gerontol Int; 2018 Jul; 18(7):1046-1050. PubMed ID: 29665183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the defect in pro-hormone processing in Type 2 diabetes mellitus restricted to the beta cell?
    Bano G; Rodin DA; White A; O'Rahilly S; Nussey SS
    Diabet Med; 2001 Jan; 18(1):17-21. PubMed ID: 11168336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific insulin and proinsulin in normal glucose tolerant first-degree relatives of NIDDM patients.
    Coifman R; Dalbosco IS; Russo EM; Moisés RS
    Braz J Med Biol Res; 1999 Jan; 32(1):67-72. PubMed ID: 10347771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan.
    Abdelgadir M; Elbagir M; Eltom M; Berne C; Ahrén B
    Metabolism; 2002 Mar; 51(3):304-6. PubMed ID: 11887164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial glucose utilisation in type II diabetes mellitus patients treated with sulphonylurea drugs.
    Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):703-8. PubMed ID: 16528523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are specific serum insulin levels low in impaired glucose tolerance and type II diabetes?: measurement with a radioimmunoassay blind to proinsulin, in the population of Wadena, Minnesota.
    Goetz FC; French LR; Thomas W; Gingerich RL; Clements JP
    Metabolism; 1995 Oct; 44(10):1371-6. PubMed ID: 7476300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proinsulin levels in patients with pancreatic diabetes are associated with functional changes in insulin secretion rather than pancreatic beta-cell area.
    Breuer TG; Menge BA; Banasch M; Uhl W; Tannapfel A; Schmidt WE; Nauck MA; Meier JJ
    Eur J Endocrinol; 2010 Oct; 163(4):551-8. PubMed ID: 20679359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating proinsulin in patients with maturity onset diabetes.
    Mako ME; Starr JI; Rubenstein AH
    Am J Med; 1977 Dec; 63(6):865-9. PubMed ID: 343587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proinsulin in pregnant women with normal glucose tolerance or mild gestational diabetes mellitus.
    Festa A; Shnawa N; Schernthaner G; Haffner SM
    Exp Clin Endocrinol Diabetes; 1999; 107(7):447-52. PubMed ID: 10595596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
    Pfützner A; Kunt T; Hohberg C; Mondok A; Pahler S; Konrad T; Lübben G; Forst T
    Diabetes Care; 2004 Mar; 27(3):682-7. PubMed ID: 14988285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.